Lv5
1190 积分 2025-05-30 加入
Engineering the Interfacial Charge Transfer Dynamics by Plasmonic S-Scheme Heterojunctions for Machine-Learning-Assisted Dual-Mode Immunoassays
16天前
已完结
An electrochemical/colorimetric dual-mode sensor for the detection of AFB1 in agricultural products based on CoFe2O4@Au nanoparticles and smartphone imaging
28天前
已完结
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions
1个月前
已完结
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis
1个月前
已完结
Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
1个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1个月前
已完结
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
1个月前
已完结
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
1个月前
已完结
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
1个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
1个月前
已完结
皖公网安备34019202002308
